GlaxoSmithKline
GSK
#213
Rank
NZ$169.21 B
Marketcap
NZ$83.87
Share price
-0.42%
Change (1 day)
45.87%
Change (1 year)

Market capitalization of GlaxoSmithKline (GSK)

Market cap: NZ$169.21 Billion

As of December 2025 GlaxoSmithKline has a market cap of NZ$169.21 Billion. This makes GlaxoSmithKline the world's 213th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of GlaxoSmithKline from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025NZ$169.21 B37.25%
2024NZ$123.29 B2.25%
2023NZ$120.57 B6.42%
2022NZ$113.30 B-29.07%
2021NZ$159.73 B25.6%
2020NZ$127.17 B-26.41%
2019NZ$172.81 B23.4%
2018NZ$140.04 B12.87%
2017NZ$124.07 B-8.78%
2016NZ$136.02 B-6.02%
2015NZ$144.73 B8.86%
2014NZ$132.94 B-15.31%
2013NZ$156.99 B22.1%
2012NZ$128.57 B-12.89%
2011NZ$147.59 B11.75%
2010NZ$132.08 B-12.52%
2009NZ$150.97 B-9.36%
2008NZ$166.56 B-8.07%
2007NZ$181.18 B-15.93%
2006NZ$215.52 B-0.04%
2005NZ$215.60 B9.35%
2004NZ$197.17 B-2.67%
2003NZ$202.58 B-6.04%
2002NZ$215.60 B-41.78%
2001NZ$370.30 B-6.85%
2000NZ$397.52 B104.24%
1999NZ$194.63 B-18.59%
1998NZ$239.07 B62.13%
1997NZ$147.46 B85.1%
1996NZ$79.66 B

End of Day market cap according to different sources

On Dec 17th, 2025 the market cap of GlaxoSmithKline was reported to be:

NZ$171.79 Billion
by Nasdaq info icon info icon
NZ$169.93 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
AstraZeneca
AZN
NZ$486.71 B 187.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
NZ$245.98 B 45.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$432.30 B 155.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$448.98 B 165.34%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
NZ$202.57 B 19.72%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
NZ$59.66 B-64.74%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Dynavax Technologies
DVAX
NZ$2.20 B-98.69%๐Ÿ‡บ๐Ÿ‡ธ USA